Skip to main content
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1977;70(Suppl 3):114–117. doi: 10.1177/00359157770700S335

Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

R C Bucknall 1
PMCID: PMC1543589  PMID: 122656

Full text

PDF
114

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOCH K. J., BUCHANAN W. W., WOHL M. J., BUNIM J. J. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) 1965 May;44:187–231. [PubMed] [Google Scholar]
  2. Bacon P. A., Tribe C. R., Mackenzie J. C., Verrier-Jones J., Cumming R. H., Amer B. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. Q J Med. 1976 Oct;45(180):661–684. [PubMed] [Google Scholar]
  3. Behan P. O., Simpson J. A., Dick H. Letter: Immune response genes in myasthenia gravis. Lancet. 1973 Nov 3;302(7836):1033–1033. doi: 10.1016/s0140-6736(73)91130-6. [DOI] [PubMed] [Google Scholar]
  4. Bucknall R. C., Dixon A St J., Glick E. N., Woodland J., Zutshi D. W. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis. Br Med J. 1975 Mar 15;1(5958):600–602. doi: 10.1136/bmj.1.5958.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Czlonkowska A. Myasthenia syndrome during penicillamine treatment. Br Med J. 1975 Jun 28;2(5973):726–727. doi: 10.1136/bmj.2.5973.726-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dawkins R. L., Zilko P. J., Owen E. T. Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis. Br Med J. 1975 Dec 27;4(5999):759–760. doi: 10.1136/bmj.4.5999.759-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Delrieu F., Menkes C. J., Sainte-Croix A., Delbarre F., Babinet P., Chesneau A. M. Myasthénie et thyroïdite auto-immune au cours d'une polyarthrite rhumatoïde traitée par la D-pénicillamine. Nouv Presse Med. 1975 Nov 22;4(40):2890(1)–2890(1). [PubMed] [Google Scholar]
  8. Feltkamp T. E., van den Berg-Loonen P. M., Nijenhuis L. E., Engelfriet C. P., van Rossum A. L., van Loghem J. J., Oosterhuis H. J. Myasthenia gravis, autoantibodies, and HL-A antigens. Br Med J. 1974 Jan 26;1(5899):131–133. doi: 10.1136/bmj.1.5899.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lindstrom J. M., Lennon V. A., Seybold M. E., Whittingham S. Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann N Y Acad Sci. 1976;274:254–274. doi: 10.1111/j.1749-6632.1976.tb47691.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES